Nymox Pharmaceutical Corporation DPO Ratio 2011-2026 | NYMX

Annual DPO Ratio Nymox Pharmaceutical Corporation

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	2.41 K	4.19 K	3.12 K	1.04 K	1.27 K	807

All numbers in USD currency

Maximum	Minimum	Average
4.19 K	807	2.14 K

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
Acasti Pharma ACST	4.39 K	-	4.01 %	$ 150 M	Canada
Kamada Ltd. KMDA	106	$ 8.81	1.73 %	$ 260 M	Israel
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
Evogene Ltd. EVGN	62.6	$ 0.81	-9.28 %	$ 27.9 M	Israel
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Albireo Pharma ALBO	1.59 K	-	-0.23 %	$ 916 M	USA
Aptorum Group Limited APM	405	$ 0.79	-1.29 %	$ 4.31 M	China
XTL Biopharmaceuticals Ltd. XTLB	224	$ 0.88	-1.43 %	$ 442 M	Israel
Ampio Pharmaceuticals AMPE	2.85 K	-	-11.43 %	$ 502 K	USA
Acorda Therapeutics ACOR	277	-	-24.86 %	$ 820 K	USA
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
Arena Pharmaceuticals ARNA	142	-	-6.81 %	$ 3.04 B	USA
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
Aytu BioScience AYTU	186	$ 2.36	2.27 %	$ 14.8 M	USA
AstraZeneca PLC AZN	265	-	-	$ 96.9 B	Britain
Brickell Biotech BBI	105	-	-5.38 %	$ 6.06 M	USA
Codexis CDXS	98.4	$ 1.17	-0.85 %	$ 85.9 M	USA
Amneal Pharmaceuticals AMRX	21.1	$ 14.49	-0.75 %	$ 4.48 B	USA
AIkido Pharma AIKI	32.8 K	-	1.93 %	$ 17.4 M	USA